Effects of immunosuppressive drugs on viability and susceptibility of adipose- and bone marrow-derived mesenchymal stem cells.

Published on Apr 16, 2015in Frontiers in Immunology5.085
· DOI :10.3389/FIMMU.2015.00131
Wakako Tsuji12
Estimated H-index: 12
(University of Pittsburgh),
Jonas T. Schnider11
Estimated H-index: 11
(University of Pittsburgh)
+ 7 AuthorsVijay S. Gorantla27
Estimated H-index: 27
(University of Pittsburgh)
Sources
Abstract
The immunomodulatory potential of cell therapies using adipose-derived stem cells (ASCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) has been studied in vascularized composite allotransplantation (VCA). Most cell therapy-based experimental and clinical protocols integrate some degree of recipient conditioning/induction with antibodies or other immunosuppressive agents. We investigated the susceptibility of ASCs and BM-MSCs to anti-lymphocyte serum (ALS) and tacrolimus. Rat ASCs and BM-MSCs were exposed to varying concentrations of tacrolimus and ALS in vitro. Serum from ALS-treated animals was added to cell cultures. Viability, susceptibility, and cytotoxicity parameters were evaluated. ALS inhibited ASC and BM-MSC viability and susceptibility in vitro in a dose-dependent manner. ASCs were more susceptible to both ALS and tacrolimus than BM-MSCs. Trypsinized and adherent ASCs were significantly smaller than BM-MSCs. This is the first report on the viability and susceptibility characteristics of BM-MSCs or ASCs to collateral effects of ALS and tacrolimus. These in vitro insights may impact choice of cell type as well as concomitant conditioning agents and the logistical coordination of the timing, dosing, and frequency of drug or cell therapy in solid organ transplantation or VCA protocols.
📖 Papers frequently viewed together
54 Citations
21 Citations
3 Citations
References31
Newest
#1Ahmed Lotfy (Mansoura University)H-Index: 13
#2Mohamed Salama (Mansoura University)H-Index: 21
Last. Mohamed A. Sobh (Mansoura University)H-Index: 28
view all 6 authors...
Background and Objectives: Stem cell technology offers a new hope for many chronic disorders patients. The types of stem cells are different with many differences existing between each type. Mesenchymal stem cells (MSCs) represent one type of adult stem cells that can be easily isolated, then re-transplanted to the patients. This offers potential for their future application in treating many disorders without fear of rejection possibility. MSCs can be isolated from different sources e.g. bone ma...
80 CitationsSource
#1Lauren E. Kokai (University of Pittsburgh)H-Index: 14
#2Kacey G. Marra (University of Pittsburgh)H-Index: 64
Last. J. Peter Rubin (University of Pittsburgh)H-Index: 60
view all 3 authors...
There is a clear clinical need for cell therapies to repair or regenerate tissue lost to disease or trauma. Adipose tissue is a renewable source of stem cells, called adipose-derived stem cells (ASCs), that release important growth factors for wound healing, modulate the immune system, decrease inflammation, and home in on injured tissues. Therefore, ASCs may offer great clinical utility in regenerative therapies for afflictions such as Parkinson's disease and Alzheimer's disease, spinal cord in...
165 CitationsSource
#1Jan A. Plock (University of Pittsburgh)H-Index: 23
#2Jonas T. Schnider (University of Pittsburgh)H-Index: 11
Last. Vijay S. Gorantla (University of Pittsburgh)H-Index: 27
view all 5 authors...
Reconstructive transplantation has emerged as clinical reality over the past decade. Utilizing standard immunosuppressive drugs has proven feasible in face and hand transplantation to achieve long-term graft acceptance. As vascularized composite tissue allotransplantation is not a life-saving procedure compared to solid organ transplantation alternative protocols with less long-term side effects are even more desirable. Allograft tolerance is the holy grail of many cell-based concepts and recent...
34 CitationsSource
Background Peripheral vascular disease of the lower extremities comprises a clinical spectrum that extends from no symptoms to presentation with critical limb ischemia (CLI). Bone marrow derived Mesenchymal Stem Cells (BM- MSCs) may ameliorate the consequences of CLI due to their combinatorial potential for inducing angiogenesis and immunomodulatory environment in situ. The primary objective was to determine the safety of BM- MSCs in patients with CLI.
148 CitationsSource
#1Marcella Franquesa (EUR: Erasmus University Rotterdam)H-Index: 29
#2Carla C. Baan (EUR: Erasmus University Rotterdam)H-Index: 62
Last. Martin J. Hoogduijn (EUR: Erasmus University Rotterdam)H-Index: 57
view all 9 authors...
Summary Mesenchymal stem cells (MSCs) possess immunomodulatory properties which are of key interest for their application in autoimmunity and transplantation. In transplantation, administration of MSCs has shown promising results in preclinical models and has recently moved to clinical trials. Therefore, it is important to study the interactions between MSCs and immunosuppressive drugs currently used in transplantation. We aimed to analyze the effect of rabbit antithymocyte globulin (rATG) MSCs....
9 CitationsSource
#1Jan A. Plock (University of Pittsburgh)H-Index: 23
#2Jonas T. Schnider (University of Pittsburgh)H-Index: 11
Last. Vijay S. Gorantla (University of Pittsburgh)H-Index: 27
view all 4 authors...
Mesenchymal stromal cells (MSCs) are under investigation for clinical application. Despite approval by the United States Food and Drug Administration for MSC use in pediatric steroid-refractory acute GvHD after allogeneic hematopoietic stem cell transplantation (Parekkadan and Milwid, 2010) uncertainty about the fate of MSCs after infusion remains thus far. Clinical trials have provided evidence for high response rates, efficacy, and safety leading to mortality reduction after MSC treatment of G...
22 CitationsSource
#1Stefan Schneeberger (Innsbruck Medical University)H-Index: 39
#2Vijay S. Gorantla (University of Pittsburgh)H-Index: 27
Last. W. P. Andrew Lee (Johns Hopkins University)H-Index: 36
view all 26 authors...
Over 150 composite tissue allotransplantations have been performed to date with highly encouraging outcomes.1 In the combined American and European experience, graft survival is greater than 90%. However, 1 patient died from sepsis after combined hand and face transplantation and another developed avascular hip necrosis, emphasizing the importance of minimizing immunosuppression after such non-life-saving transplants. Donor bone marrow (BM) infusion has been attempted in selected cases of solid ...
154 CitationsSource
#1Hong XuH-Index: 15
#2Deborah M. RamseyH-Index: 1
Last. Suzanne T. IldstadH-Index: 55
view all 5 authors...
Background Approaches to safely induce tolerance in vascularized composite allotransplantation (VCA) with chimerism through bone marrow transplantation (BMT) are currently being pursued. However, the VCA were historically performed sequentially after donor chimerism was established. Delayed VCA is not clinically applicable due to the time constraints associated with procurement from deceased donors. A more clinically relevant approach to perform both the BMT and VCA simultaneously was evaluated.
12 CitationsSource
#1Yanwen PengH-Index: 16
#2Ming KeH-Index: 2
Last. Andy Peng XiangH-Index: 1
view all 14 authors...
Abstract The deleterious side effects of calcineurin inhibitors have impaired long-term survival after renal allograft. New immunotherapy regimens that minimize or even eliminate calcineurin inhibitors are required to improve transplantation outcome. Mesenchymal stem cells (MSCs) represent a unique cell population with immunosuppressive function and prolong allograft survival in experimental organ transplant models. In this pilot study, donor-derived bone marrow MSCs combined with a sparing dose...
129 CitationsSource
#1Francesco Dazzi (Imperial College London)H-Index: 67
#2Luciene Lopes (Imperial College London)H-Index: 1
Last. Ling Weng (Imperial College London)H-Index: 7
view all 3 authors...
The existence of a mesenchymal stromal cell (MSC) population with the main property of physically supporting parenchymal tissues has long been recognized in virtually all organs. However, it was only recently that MSC have been identified as playing a novel role in modulating inflammation. It has been extensively documented that, under particular circumstances, MSC potently impair virtually all cells of the immune system, including antigen-presenting-cells.
62 CitationsSource
Cited By18
Newest
#1Fereshteh AzediH-Index: 4
#2Kazem MousavizadehH-Index: 15
Last. Mohammad Taghi JoghataeiH-Index: 28
view all 3 authors...
Source
#1Martin Molitor (First Faculty of Medicine, Charles University in Prague)H-Index: 5
#2Martina Travnickova (CAS: Academy of Sciences of the Czech Republic)H-Index: 7
Last. Stefano LucchinaH-Index: 1
view all 7 authors...
BACKGROUND An understanding of fat grafting methodology, techniques and patient-related factors is crucial when considering fat grafting. Multiple factors can influence the success of a fat graft and consequently the outcome of the procedure. The aim of this systematic review is to elucidate the influence of negative pressure and various techniques of fat harvesting on the viability and function of cells, particularly adipocytes and adipose-derived stem cells. METHODS We conducted a literature s...
2 CitationsSource
#1Yafei Qin (Tianjin Medical University General Hospital)H-Index: 4
#2Dejun Kong (Tianjin Medical University General Hospital)H-Index: 2
Last. Hao Wang (Tianjin Medical University General Hospital)H-Index: 10
view all 10 authors...
Background: Chronic rejection characterized by chronic allograft vasculopathy (CAV) remains a major obstacle to long-term graft survival. Due to multiple complicated mechanisms involved, a novel therapy for CAV remains exploration. Although mesenchymal stromal cells (MSCs) have been ubiquitously applied to various refractory immune-related diseases, rare research makes a thorough inquiry in CAV. Meanwhile, melatonin (MT), a wide spectrum of immunomodulator, plays a non-negligible role in transpl...
Source
#1Yi-Chuan Xu (SYSU: Sun Yat-sen University)H-Index: 1
#2Yansi LinH-Index: 2
Last. Rui-Fang Fan (SYSU: Sun Yat-sen University)H-Index: 3
view all 8 authors...
Background Acute myeloid leukemia (AML) is a malignant hematological disease, originating from hematopoiesis stem cell differentiation obstruction and clonal proliferation. New reagents or biologicals for the treatment of AML are urgently needed, and exosomes have been identified as candidate biomarkers for disease diagnosis and prognosis. This study aimed to investigate the effects of exosomes from bone marrow mesenchymal stem cells (BMSCs) on AML cells as well as the underlying microRNA (miRNA...
1 CitationsSource
#1Ali Moshiri (IUMS: Iran University of Medical Sciences)H-Index: 26
#2Neda Tekyieh Maroof (IUMS: Iran University of Medical Sciences)
Last. Ali Sharifi (UM: University of Malaya)H-Index: 32
view all 3 authors...
Objective(s): We investigated the role of various biomaterials on cell viability and in healing of an experimentally induced femoral bone hole model in rats.Materials and Methods: Cell viability and cytotoxicity of gelatin (Gel; 50 µg/µl), chitosan (Chi; 20 µg/µl), hydroxyapatite (HA; 50 µg/µl), nanohydroxyapatite (nHA; 10 µg/µl), three-calcium phosphate (TCP; 50 µg/µl) and strontium carbonate (Sr; 10 µg/µl) were evaluated on hADSCs via MTT assay. In vivo femoral drill-bone hole model was produc...
Source
#1Pranitha Kamat (UZH: University of Zurich)H-Index: 6
#2Florian S. Frueh (UZH: University of Zurich)H-Index: 13
Last. Johanna Buschmann (UZH: University of Zurich)H-Index: 21
view all 9 authors...
Abstract Tissue defects in the human body after trauma and injury require precise reconstruction to regain function. Hence, there is a great demand for clinically translatable approaches with materials that are both biocompatible and biodegradable. They should also be able to adequately integrate within the tissue through sufficient vascularization. Adipose tissue is abundant and easily accessible. It is a valuable tissue source in regenerative medicine and tissue engineering, especially with re...
5 CitationsSource
#1Riccardo Schweizer (University of Pittsburgh)H-Index: 14
#2Matthias Waldner (University of Pittsburgh)H-Index: 6
Last. J. Peter Rubin (University of Pittsburgh)H-Index: 60
view all 11 authors...
Background: Mesenchymal stromal cell (MSC)-based cytotherapies fuel the hope for reduction of chronic systemic immunosuppression in allotransplantation, and our group has previously shown this capability for both swine and human cells. MSCs harvested from distinct anatomical locations may have different behavior and lead to different outcomes in both preclinical research and human trials. To provide an effective reference for cell therapy studies, we compared human and porcine MSCs from omental ...
3 CitationsSource
#1Sadaki Mitsuzawa (Kyoto University)H-Index: 4
#2Ryosuke Ikeguchi (Kyoto University)H-Index: 14
Last. Shuichi Matsuda (Kyoto University)H-Index: 64
view all 12 authors...
BACKGROUND: The reduction of systemic immunosuppressive agents is essential for the expansion of vascularized composite allotransplantation (VCA) in a clinical setting. The purpose of this study is to compare human-induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) with four other types of mesenchymal stem cells (human bone marrow-derived MSCs [BMMSCs], human adipose-derived MSCs [ADMSCs], rat BMMSCs, and rat ADMSCs) in vitro, and to investigate the in vivo immunomodulatory eff...
4 CitationsSource
#1Ilenia MastroliaH-Index: 5
#2Elisabetta Manuela Foppiani (Emory University)H-Index: 4
Last. Massimo DominiciH-Index: 51
view all 9 authors...
: Identified 50 years ago, mesenchymal stromal/stem cells (MSCs) immediately generated a substantial interest among the scientific community because of their differentiation plasticity and hematopoietic supportive function. Early investigations provided evidence of a relatively low engraftment rate and a transient benefit for challenging congenital and acquired diseases. The reasons for these poor therapeutic benefits forced the entire field to reconsider MSC mechanisms of action together with t...
67 CitationsSource
#1Gözde Sır (Ege University)H-Index: 1
#2Bakiye Goker Bagca (Ege University)H-Index: 8
Last. Yiğit Uyanıkgil (Ege University)H-Index: 14
view all 7 authors...
Abstract Tacrolimus (FK506) is a chemotherapeutic agent, which uses calcineurin pathway via inhibiting the stimulation of T cells to prevent the formation of immune response in the recipient individual in organ transplants. FK506 is mainly metabolized in the liver by cytochrome P450 enzyme system and is known that it has high toxic effects on different cells. Mesenchymal stem cells (MSCs) have recently gained importance since their potential to be used in cellular therapy and tissue regeneration...
3 CitationsSource